| Insideraktier | 9.981.306 shares |
| Total Insiders | 28 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Atrium Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Alexandria Venture Investments, LLC
10% Owner -
|
502.365 | 502.365 | |
| Carsten Boess Director - [D] | 0 | 0 | |
| Sarah Boyce President and CEO, Director - [D] [O] | 0 | 0 | |
| Todd C Brady | 0 | ||
| Charles III Calderaro Chief Technical Officer - [O] | 0 | 0 | |
|
Bihua Chen
Director, 10% Owner -
[D]
|
2.514.545 | 2.514.545 | |
| Cormorant Asset Management, LLC - | 2.514.545 | 2.514.545 | |
|
Cormorant Global Healthcare Master Fund, LP
10% Owner -
|
2.514.545 | 2.514.545 | |
|
Cormorant Private Healthcare Fund II, LP
10% Owner -
|
2.514.545 | 2.514.545 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Flanagan W. Michael Chief Scientific Officer - [O] | 0 | 0 | |
| Gallagher Kathleen P. Chief Program Officer - [O] | 0 | 0 | |
| Noreen Henig Director - [D] | 0 | 0 | |
| Steven George Hughes Chief Medical Officer - [O] | 0 | 0 | |
| Kaye Edward M. MD Director - [D] | 0 | 0 | |
| Kim Jae B. | 375.266 | ||
| Jean Jinsun Kim Director - [D] | 0 | 0 | |
| Arthur A Levin Director - [D] | 0 | 0 | |
|
Eli & Co Lilly
10% Owner -
|
2.169.396 | 2.169.396 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Michael F MacLean Chief Financial Officer - [O] | 0 | 0 | |
| Martin Michael B. | 0 | ||
| Teresa McCarthy Chief Human Resources Officer - [O] | 0 | 0 | |
| John B Moriarty Chief Legal Officer - [O] | 0 | 0 | |
| Eric Mosbrooker Chief Commercial Officer - [O] | 0 | 0 | |
|
Rtw Investments, Lp
10% Owner -
|
4.795.000 | 4.795.000 | |
| Simona Skerjanec Director - [D] | 0 | 0 | |
| Tamar Thompson Director - [D] | 0 | 0 | |
| Troy Edward Wilson Director - [D] | 0 | 0 | |
|
Roderick Wong
Director, 10% Owner -
[D]
|
4.795.000 | 4.795.000 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RNA / Atrium Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RNA / Atrium Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-27 | 4 | McCarthy Teresa | RNAM | Common Stock | D | -165.296 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Thompson Tamar | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | MacLean Michael F | RNAM | Common Stock | D | -133.977 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Skerjanec Simona | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Boyce Sarah | RNAM | Common Stock | D | -474.861 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Hughes Steven George | RNAM | Common Stock | D | -115.857 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Moriarty John B | RNAM | Common Stock | D | -92.054 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Flanagan W. Michael | RNAM | Common Stock | D | -150.365 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | WILSON TROY EDWARD By family trust | RNAM | Common Stock | I | -13.711 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | WILSON TROY EDWARD | RNAM | Common Stock | D | -65.091 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Gallagher Kathleen P. | RNAM | Common Stock | D | -80.303 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Henig Noreen | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Kim Jean Jinsun | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | LEVIN ARTHUR A By family trust | RNAM | Common Stock | I | -131.372 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | LEVIN ARTHUR A | RNAM | Common Stock | D | -16.562 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Kaye Edward M. MD | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | BOESS CARSTEN | RNAM | Common Stock | D | -6.692 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Mosbrooker Eric | RNAM | Common Stock | D | -79.413 | 0 | ||||||
| 2026-02-27 | 2026-02-27 | 4 | Calderaro Charles III | RNAM | Common Stock | D | -98.547 | 0 | ||||||
| 2026-01-23 | 2026-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,4500 | -2.878 | -209 | 31.599 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,4500 | -2.017 | -146 | 34.477 | ||||
| 2026-01-23 | 2026-01-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 72,4500 | -1.758 | -127 | 16.562 | ||||
| 2026-01-23 | 2026-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,4500 | -1.453 | -105 | 113.938 | ||||
| 2026-01-23 | 2026-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,4500 | -1.476 | -107 | 115.391 | ||||
| 2026-01-23 | 2026-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,4500 | -2.735 | -198 | 59.290 | ||||
| 2026-01-23 | 2026-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,4500 | -1.807 | -131 | 62.025 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,4500 | -2.558 | -185 | 85.093 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,4500 | -3.976 | -288 | 87.651 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,4500 | -7.993 | -579 | 269.007 | ||||
| 2026-01-23 | 2026-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,4500 | -6.394 | -463 | 277.000 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Moriarty John B | RNA | Common Stock | D | 72,2300 | -2.374 | -171 | 74.557 | ||||
| 2026-01-09 | 2026-01-07 | 4 | McCarthy Teresa | RNA | Common Stock | D | 72,2300 | -1.965 | -142 | 116.867 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Calderaro Charles III | RNA | Common Stock | D | 72,2300 | -3.727 | -269 | 49.797 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 72,2300 | -8.576 | -619 | 283.394 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 72,2300 | -2.373 | -171 | 91.627 | ||||
| 2026-01-09 | 2026-01-07 | 4 | Hughes Steven George | RNA | Common Stock | D | 72,2300 | -2.373 | -171 | 36.494 | ||||
| 2026-01-09 | 2026-01-07 | 4 | MacLean Michael F | RNA | Common Stock | D | 72,2300 | -1.974 | -143 | 63.832 | ||||
| 2025-12-22 | 2025-12-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | -1.330 | 18.320 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Calderaro Charles III | RNA | Common Stock | D | 71,8700 | -9.726 | -699 | 53.524 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Calderaro Charles III | RNA | Common Stock | D | 23.250 | 63.250 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 71,8700 | -13.695 | -984 | 94.000 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 27.500 | 107.695 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 71,8700 | -11.426 | -821 | 79.010 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 71,8700 | -36.564 | -2.628 | 90.436 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 72.000 | 127.000 | ||||||
| 2025-12-19 | 2025-12-18 | 4 | Boyce Sarah | RNA | Common Stock | D | -29.159 | 291.970 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 71,8700 | -15.742 | -1.131 | 321.129 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 31.000 | 336.871 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Moriarty John B | RNA | Common Stock | D | 71,8700 | -26.824 | -1.928 | 76.931 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Moriarty John B | RNA | Common Stock | D | 56.000 | 103.755 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 71,8700 | -8.030 | -577 | 80.838 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 71,8700 | -33.336 | -2.396 | 88.868 | ||||
| 2025-12-19 | 2025-12-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 72.000 | 122.204 | ||||||
| 2025-12-19 | 2025-12-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 71,8700 | -17.298 | -1.243 | 118.832 | ||||
| 2025-12-19 | 2025-12-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39.000 | 136.130 | ||||||
| 2025-10-24 | 2025-10-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 47,5394 | -2.209 | -105 | 38.867 | ||||
| 2025-10-24 | 2025-10-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.209 | 22 | 41.076 | ||||
| 2025-10-17 | 2025-10-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 50,1529 | -20.000 | -1.003 | 97.130 | ||||
| 2025-10-17 | 2025-10-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 20.000 | 447 | 117.130 | ||||
| 2025-10-07 | 2025-10-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 45,3781 | -6.562 | -298 | 55.000 | ||||
| 2025-10-07 | 2025-10-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 6.562 | 59 | 61.562 | ||||
| 2025-09-23 | 2025-09-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 40,5800 | -2.208 | -90 | 38.867 | ||||
| 2025-09-23 | 2025-09-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.208 | 22 | 41.075 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,4095 | -15.000 | -621 | 97.130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 15.000 | 335 | 112.130 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 45,4100 | -1.542 | -70 | 38.867 | ||||
| 2025-09-17 | 2025-09-15 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1.542 | 10 | 40.409 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 38,9351 | -20.000 | -779 | 80.195 | ||||
| 2025-09-12 | 2025-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 100.195 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | -15.000 | -750 | 54.425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 50,0000 | -14.500 | -725 | 69.425 | ||||
| 2025-09-09 | 2025-09-05 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 14.500 | 181 | 83.925 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,9487 | -50.000 | -2.497 | 305.871 | ||||
| 2025-09-05 | 2025-09-05 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 50.000 | 62 | 355.871 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 47,0723 | -6.563 | -309 | 55.000 | ||||
| 2025-09-05 | 2025-09-03 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 6.563 | 59 | 61.563 | ||||
| 2025-09-02 | 2025-09-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 47,4200 | -188 | -9 | 50.204 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 49,3880 | -25.000 | -1.235 | 305.871 | ||||
| 2025-08-29 | 2025-08-28 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 25.000 | 31 | 330.871 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,4047 | -2.208 | -102 | 38.867 | ||||
| 2025-08-22 | 2025-08-22 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 2.208 | 22 | 41.075 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 46,6600 | -1.542 | -72 | 38.867 | ||||
| 2025-08-15 | 2025-08-13 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 1.542 | 10 | 40.409 | ||||
| 2025-08-15 | 2025-08-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 42,7264 | -30.914 | -1.321 | 65.806 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 46,5632 | -10.000 | -466 | 97.130 | ||||
| 2025-08-15 | 2025-08-15 | 4 | McCarthy Teresa | RNA | Common Stock | D | 22,3400 | 10.000 | 223 | 107.130 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | -6.120 | -270 | 55.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 44,0626 | -124.687 | -5.494 | 61.120 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 9,0500 | 124.687 | 1.128 | 185.807 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 4 | RNA | Common Stock | I | 45,0000 | -17.777 | -800 | 17.776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 3 | RNA | Common Stock | I | 45,0000 | -17.777 | -800 | 17.776 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 1 | RNA | Common Stock | I | 45,0000 | -15.000 | -675 | 285.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD By irrevocable trust 2 | RNA | Common Stock | I | 45,0000 | -15.000 | -675 | 285.000 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | -7.500 | -338 | 69.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,4800 | 7.500 | 94 | 76.925 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 45,0000 | -22.000 | -990 | 69.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 12,0300 | 22.000 | 265 | 91.425 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 47,6175 | -107.500 | -5.119 | 19.650 | ||||
| 2025-08-08 | 2025-08-06 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,3400 | 107.500 | 2.402 | 127.150 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -33.983 | -1.452 | 38.867 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -17.667 | -755 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 10,1600 | 17.667 | 179 | 90.517 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -6.167 | -264 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 22,4700 | 6.167 | 139 | 79.017 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -12.334 | -527 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 6,5700 | 12.334 | 81 | 85.184 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 42,7373 | -11.283 | -482 | 72.850 | ||||
| 2025-08-08 | 2025-08-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 15,9600 | 11.283 | 180 | 84.133 | ||||
| 2025-08-05 | 2025-08-04 | 4 | Moriarty John B | RNA | Common Stock | D | 36,2100 | -2.245 | -81 | 47.755 | ||||
| 2025-06-18 | 2025-06-17 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,2400 | -911 | -28 | 50.392 | ||||
| 2025-06-12 | 2025-06-10 | 4 | Henig Noreen | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | BOESS CARSTEN | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kaye Edward M. MD | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 6.692 | 19.650 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Skerjanec Simona | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | 6.692 | 69.425 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Thompson Tamar | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-10 | 4 | Kim Jean Jinsun | RNA | Common Stock | D | 6.692 | 6.692 | ||||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,8847 | -20.000 | -658 | 80.195 | ||||
| 2025-06-12 | 2025-06-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 100.195 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,4822 | -5.875 | -191 | 50.554 | ||||
| 2025-06-04 | 2025-06-02 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,3956 | -5.875 | -190 | 50.554 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | -329 | -9 | 50.554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 329 | 5 | 50.883 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 27,8274 | -5.546 | -154 | 50.554 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5.546 | 82 | 56.100 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Hughes Steven George | RNA | Common Stock | D | 31,0598 | -9.578 | -297 | 72.850 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 31,0578 | -31.540 | -980 | 305.871 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 31,0584 | -11.780 | -366 | 80.195 | ||||
| 2025-03-21 | 2025-03-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 31,0554 | -7.935 | -246 | 96.720 | ||||
| 2025-03-21 | 2025-03-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 31,0598 | -7.778 | -242 | 97.130 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 30,1307 | -20.000 | -603 | 91.975 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 14,2200 | 20.000 | 284 | 111.975 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 29,4140 | -5.875 | -173 | 50.554 | ||||
| 2025-03-04 | 2025-03-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 14,7000 | 5.875 | 86 | 56.429 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 32,1563 | -5.875 | -189 | 50.554 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 16,6500 | 5.875 | 98 | 56.429 | ||||
| 2025-01-23 | 2025-01-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 28,5987 | -1.872 | -54 | 12.958 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5932 | -1.665 | -48 | 104.655 | ||||
| 2025-01-23 | 2025-01-21 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,5929 | -1.622 | -46 | 106.320 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5968 | -1.221 | -35 | 104.908 | ||||
| 2025-01-23 | 2025-01-21 | 4 | McCarthy Teresa | RNA | Common Stock | D | 28,5931 | -1.738 | -50 | 106.129 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5920 | -1.812 | -52 | 91.975 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 28,5967 | -3.860 | -110 | 93.787 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5946 | -5.659 | -162 | 337.411 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Boyce Sarah | RNA | Common Stock | D | 28,5932 | -4.738 | -135 | 343.070 | ||||
| 2025-01-23 | 2025-01-22 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 30,1609 | -5.629 | -170 | 50.554 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5930 | -1.817 | -52 | 56.183 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5953 | -670 | -19 | 58.000 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 28,5900 | -1.295 | -37 | 58.670 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5906 | -2.032 | -58 | 82.428 | ||||
| 2025-01-23 | 2025-01-21 | 4 | Hughes Steven George | RNA | Common Stock | D | 28,5955 | -1.915 | -55 | 84.460 | ||||
| 2025-01-08 | 2025-01-06 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.647 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 107.867 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Moriarty John B | RNA | Common Stock | D | 25.000 | 50.000 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 107.942 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 82.500 | 347.808 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Hughes Steven George | RNA | Common Stock | D | 25.000 | 86.375 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Gallagher Kathleen P. | RNA | Common Stock | D | 25.000 | 59.965 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Mosbrooker Eric | RNA | Common Stock | D | 25.000 | 61.120 | ||||||
| 2025-01-08 | 2025-01-06 | 4 | Calderaro Charles III | RNA | Common Stock | D | 40.000 | 40.000 | ||||||
| 2025-01-08 | 3 | Mosbrooker Eric | RNA | Common Stock | D | 36.120 | ||||||||
| 2025-01-08 | 3 | Gallagher Kathleen P. | RNA | Common Stock | D | 34.965 | ||||||||
| 2025-01-08 | 3 | Hughes Steven George | RNA | Common Stock | D | 61.375 | ||||||||
| 2024-12-19 | 2024-12-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 32,6600 | -12.742 | -416 | 72.647 | ||||
| 2024-12-19 | 2024-12-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 32,6600 | -31.855 | -1.040 | 265.308 | ||||
| 2024-12-19 | 2024-12-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 32,6600 | -11.151 | -364 | 82.942 | ||||
| 2024-12-19 | 2024-12-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 32,6600 | -11.151 | -364 | 82.867 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 33,2642 | -25.000 | -832 | 94.018 | ||||
| 2024-12-18 | 2024-12-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 35,7667 | -24.000 | -858 | 85.389 | ||||
| 2024-12-13 | 2024-12-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 24.000 | 539 | 109.389 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 41,1408 | -25.000 | -1.029 | 94.018 | ||||
| 2024-11-20 | 2024-11-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 42,1224 | -3.323 | -140 | 14.830 | ||||
| 2024-11-20 | 2024-11-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3.323 | 4 | 18.153 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | -13.875 | -629 | 94.093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 6,5700 | 13.875 | 91 | 107.968 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 45,3339 | -65.182 | -2.955 | 94.093 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 65.182 | 575 | 159.275 | ||||
| 2024-11-08 | 2024-11-06 | 4 | MacLean Michael F | RNA | Common Stock | D | 46,2188 | -27.262 | -1.260 | 94.093 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 46,6335 | -5.000 | -233 | 14.830 | ||||
| 2024-10-23 | 2024-10-21 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 48,5204 | -25.000 | -1.213 | 94.018 | ||||
| 2024-10-17 | 2024-10-16 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 119.018 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 44,9753 | -30.000 | -1.349 | 0 | ||||
| 2024-10-09 | 2024-10-07 | 4 | Thompson Tamar | RNA | Common Stock | D | 27,6300 | 30.000 | 829 | 30.000 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 47,6178 | -62.500 | -2.976 | 85.389 | ||||
| 2024-10-03 | 2024-10-01 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62.500 | 1.672 | 147.889 | ||||
| 2024-09-23 | 2024-09-23 | 4 | McCarthy Teresa | RNA | Common Stock | D | 44,0004 | -13.153 | -579 | 69.018 | ||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 94.018 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 94.018 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 43,8926 | -11.847 | -520 | 85.389 | ||||
| 2024-09-23 | 2024-09-23 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 44,0004 | -13.153 | -579 | 72.718 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.718 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 97.718 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | Boyce Sarah | RNA | Common Stock | D | 44,0001 | -32.880 | -1.447 | 234.663 | ||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 297.163 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 297.163 | ||||||
| 2024-09-23 | 2024-09-23 | 4 | MacLean Michael F | RNA | Common Stock | D | 44,0000 | -11.510 | -506 | 96.355 | ||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 121.355 | ||||||
| 2024-09-23 | 2024-09-19 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 121.355 | ||||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,7316 | -5.000 | -229 | 14.830 | ||||
| 2024-09-20 | 2024-09-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3972 | -14.894 | -602 | 60.871 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,3987 | -34.000 | -1.374 | 75.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 22,4700 | 34.000 | 764 | 109.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40,4002 | -62.500 | -2.525 | 75.765 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 26,7500 | 62.500 | 1.672 | 138.265 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 40,4017 | -25.000 | -1.010 | 57.171 | ||||
| 2024-09-13 | 2024-09-11 | 4 | McCarthy Teresa | RNA | Common Stock | D | 14,2200 | 25.000 | 356 | 82.171 | ||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 22.500 | 22.500 | ||||||
| 2024-09-10 | 2024-09-06 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | -22.500 | 131.372 | ||||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,1893 | -5.000 | -226 | 14.830 | ||||
| 2024-08-21 | 2024-08-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 43,3508 | -28.000 | -1.214 | 205.043 | ||||
| 2024-08-07 | 2024-08-06 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 233.043 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Moriarty John B | RNA | Common Stock | D | 25.000 | 25.000 | ||||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 45,0138 | -5.000 | -225 | 14.830 | ||||
| 2024-07-23 | 2024-07-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,9315 | -28.000 | -1.118 | 205.043 | ||||
| 2024-07-11 | 2024-07-09 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 233.043 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 37,5901 | -5.000 | -188 | 14.830 | ||||
| 2024-06-21 | 2024-06-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-06-20 | 2024-06-18 | 4 | McCarthy Teresa | RNA | Common Stock | D | 39,1294 | -9.864 | -386 | 32.171 | ||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 57.171 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | McCarthy Teresa | RNA | Common Stock | D | 25.000 | 57.171 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Boyce Sarah | RNA | Common Stock | D | 39,1295 | -32.074 | -1.255 | 142.543 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 205.043 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 205.043 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | MacLean Michael F | RNA | Common Stock | D | 39,1294 | -11.228 | -439 | 57.865 | ||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 82.865 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | MacLean Michael F | RNA | Common Stock | D | 25.000 | 82.865 | ||||||
| 2024-06-20 | 2024-06-18 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 39,1297 | -10.106 | -395 | 50.765 | ||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 75.765 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 25.000 | 75.765 | ||||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 35,7153 | -104.245 | -3.723 | 44.093 | ||||
| 2024-06-14 | 2024-06-12 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 104.245 | 919 | 148.338 | ||||
| 2024-06-14 | 2024-06-13 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 40,0797 | -60.000 | -2.405 | 153.872 | ||||
| 2024-06-14 | 2024-06-12 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 35,0657 | -40.000 | -1.403 | 213.872 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0784 | -35.767 | -1.433 | 112.117 | ||||
| 2024-06-14 | 2024-06-14 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35.767 | 44 | 147.884 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 40,0760 | -164.233 | -6.582 | 112.117 | ||||
| 2024-06-14 | 2024-06-13 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 164.233 | 204 | 276.350 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 35,7302 | -100.000 | -3.573 | 112.117 | ||||
| 2024-06-14 | 2024-06-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100.000 | 124 | 212.117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 27,4207 | -28.000 | -768 | 112.117 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,8962 | -5.000 | -149 | 14.830 | ||||
| 2024-05-21 | 2024-05-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 28,2806 | -75.000 | -2.121 | 44.093 | ||||
| 2024-05-16 | 2024-05-14 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 75.000 | 662 | 119.093 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 25,5375 | -28.000 | -715 | 112.117 | ||||
| 2024-05-07 | 2024-05-07 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,8246 | -5.000 | -114 | 14.830 | ||||
| 2024-04-22 | 2024-04-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-04-03 | 2024-04-03 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 27,1107 | -20.000 | -542 | 253.872 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 26,2471 | -28.000 | -735 | 112.117 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,9695 | -5.000 | -120 | 14.830 | ||||
| 2024-03-21 | 2024-03-19 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 5.000 | 6 | 19.830 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 24,5190 | -40.000 | -981 | 44.093 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacLean Michael F | RNA | Common Stock | D | 8,8200 | 40.000 | 353 | 84.093 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | -2.641 | -58 | 14.830 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0366 | -25.000 | -551 | 17.471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 25.000 | 31 | 42.471 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,6315 | -28.000 | -634 | 112.117 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 28.000 | 35 | 140.117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 21,3894 | -84.000 | -1.797 | 112.117 | ||||
| 2024-03-12 | 2024-03-08 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84.000 | 104 | 196.117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 20,1346 | -84.000 | -1.691 | 112.117 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 84.000 | 104 | 196.117 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Boyce Sarah | RNA | Common Stock | D | 10,1300 | -5.092 | -52 | 44.008 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 62.500 | 67.209 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 10,1300 | -1.859 | -19 | 17.471 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 10,1300 | -4.129 | -42 | 35.871 | ||||
| 2024-01-23 | 2024-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 20.000 | 20.290 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | McCarthy Teresa | RNA | Common Stock | D | 10,1300 | -2.065 | -21 | 17.035 | ||||
| 2024-01-23 | 2024-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 16.500 | 17.458 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | MacLean Michael F | RNA | Common Stock | D | 10,1300 | -1.616 | -16 | 16.884 | ||||
| 2024-01-23 | 2024-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 22.500 | 27.209 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 3 and 4 | RNA | Common Stock | I | 250.000 | 300.000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | -250.000 | 13.711 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By trust FBO Children 1 and 2 | RNA | Common Stock | I | 300.000 | 300.000 | ||||||
| 2023-12-14 | 2023-12-12 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | -300.000 | 263.711 | ||||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0100 | -100 | -2 | 19.330 | ||||
| 2023-03-17 | 2023-03-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 19.430 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 24,2381 | -523 | -13 | 19.330 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 23,6246 | -9.477 | -224 | 19.853 | ||||
| 2023-02-15 | 2023-02-14 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10.000 | 12 | 29.330 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2600 | -3.221 | -78 | 53.352 | ||||
| 2023-02-03 | 2023-02-03 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 3.221 | 4 | 56.573 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,3628 | -45.879 | -1.118 | 53.352 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 45.879 | 57 | 99.231 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 24,2716 | -900 | -22 | 53.352 | ||||
| 2023-02-03 | 2023-02-01 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 900 | 1 | 54.252 | ||||
| 2023-01-24 | 2023-01-20 | 4 | Boyce Sarah | RNA | Common Stock | D | 50.000 | 53.352 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | Flanagan W. Michael | RNA | Common Stock | D | 40.000 | 40.290 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 18.000 | 19.330 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | MacLean Michael F | RNA | Common Stock | D | 18.500 | 21.852 | ||||||
| 2023-01-24 | 2023-01-20 | 4 | McCarthy Teresa | RNA | Common Stock | D | 20.000 | 20.958 | ||||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0028 | -10.000 | -220 | 1.330 | ||||
| 2023-01-17 | 2023-01-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 10.000 | 12 | 11.330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0142 | -40.000 | -881 | 1.330 | ||||
| 2023-01-03 | 2022-12-29 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 40.000 | 50 | 41.330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0798 | -3.499 | -77 | 1.330 | ||||
| 2022-08-31 | 2022-08-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 3.499 | 4 | 4.829 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,1182 | -62.498 | -1.382 | 1.330 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 34.758 | 43 | 63.828 | ||||
| 2022-08-31 | 2022-08-15 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 27.740 | 15 | 29.070 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 22,0000 | -14.003 | -308 | 1.330 | ||||
| 2022-08-31 | 2022-08-12 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 14.003 | 7 | 15.333 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 23,0690 | -14.855 | -343 | 0 | ||||
| 2022-08-26 | 2022-08-25 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 14.855 | 18 | 14.855 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,7971 | -35.045 | -799 | 0 | ||||
| 2022-08-26 | 2022-08-24 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 35.045 | 43 | 35.045 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 22,4700 | -100 | -2 | 0 | ||||
| 2022-08-17 | 2022-08-15 | 4 | Boyce Sarah | RNA | Common Stock | D | 1,2400 | 100 | 0 | 100 | ||||
| 2022-03-15 | 2022-01-21 | 4 | McCarthy Teresa | RNA | Stock Option (Right to Buy) | D | 14,22 | 157.500 | 157.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 14,22 | 136.500 | 136.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 14,22 | 131.250 | 131.250 | |||||
| 2022-03-15 | 2022-01-21 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 14,22 | 115.500 | 115.500 | |||||
| 2022-03-15 | 2022-01-21 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 14,22 | 425.000 | 425.000 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -604 | 41.743 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -24.396 | 166.770 | |||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8887 | -25.000 | -697 | 1.330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 604 | 0 | 26.330 | ||||
| 2021-11-22 | 2021-11-18 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 24.396 | 30 | 25.726 | ||||
| 2021-08-27 | 2021-08-25 | 4 | Mosbrooker Eric | RNA | Stock Option (Right to Buy) | D | 20,83 | 30.000 | 30.000 | |||||
| 2021-08-06 | 2021-08-04 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Common Stock | I | 18,0000 | 800.000 | 14.400 | 4.795.000 | ||||
| 2021-08-06 | 2020-06-11 | 4 | RTW INVESTMENTS, LP By RTW | RNA | Series C Preferred Stock | I | -3.995.000 | 0 | ||||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -3.083 | 42.347 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -17.017 | 191.166 | |||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 29,1398 | -2.647 | -77 | 1.330 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,9703 | -17.453 | -488 | 3.977 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 3.083 | 2 | 21.430 | ||||
| 2021-06-28 | 2021-06-25 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 17.017 | 21 | 18.347 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -100 | 208.183 | |||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7550 | -100 | -3 | 1.330 | ||||
| 2021-06-28 | 2021-06-24 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 100 | 0 | 1.430 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -200 | 208.283 | |||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,7500 | -200 | -6 | 1.330 | ||||
| 2021-06-22 | 2021-06-17 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 200 | 0 | 1.530 | ||||
| 2021-06-17 | 2021-06-16 | 4 | WONG RODERICK | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 26,0249 | -23.019 | -599 | 0 | ||||
| 2021-06-16 | 2021-06-14 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 25,9174 | -14.003 | -363 | 23.019 | ||||
| 2021-06-16 | 2021-06-16 | 4 | WILSON TROY EDWARD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Kaye Edward M. MD | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | Henig Noreen | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-06-16 | 2021-06-16 | 4 | BOESS CARSTEN | RNA | Stock Option (Right to Buy) | D | 26,09 | 15.000 | 15.000 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 0,53 | -1.975 | 45.430 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 1,24 | -2.625 | 208.483 | |||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 27,8655 | -4.600 | -128 | 0 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 0,5300 | 1.975 | 1 | 4.600 | ||||
| 2021-03-18 | 2021-03-16 | 4 | LEVIN ARTHUR A | RNA | Common Stock | D | 1,2400 | 2.625 | 3 | 2.625 | ||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By charitable remainder trust | RNA | Common Stock | I | 37.022 | 37.022 | ||||||
| 2021-03-18 | 2021-03-05 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | -37.022 | 273.872 | ||||||
| 2021-02-04 | 2021-02-02 | 4 | Boyce Sarah | RNA | Stock Option (Right to Buy) | D | 22,34 | 300.000 | 300.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | MacLean Michael F | RNA | Stock Option (Right to Buy) | D | 22,34 | 92.000 | 92.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | LEVIN ARTHUR A | RNA | Stock Option (Right to Buy) | D | 22,34 | 120.000 | 120.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 22,34 | 82.000 | 82.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Baroldi Joseph | RNA | Stock Option (Right to Buy) | D | 22,34 | 87.000 | 87.000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Flanagan W. Michael | RNA | Stock Option (Right to Buy) | D | 26,75 | 150.000 | 150.000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Kim Jean Jinsun | RNA | Stock Option (Right to Buy) | D | 27,63 | 30.000 | 30.000 | |||||
| 2021-01-11 | 2021-01-11 | 4 | Thompson Tamar | RNA | Stock Option (Right to Buy) | D | 27,63 | 30.000 | 30.000 | |||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD By family trust 2 | RNA | Common Stock | I | 100.000 | 100.000 | ||||||
| 2020-12-28 | 2020-12-22 | 4 | WILSON TROY EDWARD | RNA | Common Stock | D | -100.000 | 89.618 | ||||||
| 2020-07-27 | 2020-07-27 | 4 | Kim Jae B. | RNA | Stock Option (Right to Buy) | D | 25,05 | 375.266 | 375.266 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC | RNA | Series C Convertible Preferred Stock | D | 2.214.545 | 0 | ||||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 18,0000 | 300.000 | 5.400 | 2.514.545 | ||||
| 2020-06-18 | 2020-06-16 | 4 | Cormorant Asset Management, LLC See Footnotes | RNA | Common Stock | I | 2.214.545 | 2.214.545 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Series C Preferred Stock | D | -4.576.342 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LILLY ELI & CO | RNA | Common Stock | D | 2.169.396 | 2.169.396 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series C convertible preferred stock | D | -134.126 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series B convertible preferred stock | D | -530.616 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Series A convertible preferred stock | D | -395.000 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | Alexandria Venture Investments, LLC | RNA | Common stock | D | 502.365 | 502.365 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Series A Preferred Stock | I | -35.337 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 16.751 | 310.894 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Series C Preferred Stock | I | -6.423.431 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 18,0000 | 950.000 | 17.100 | 3.995.000 | ||||
| 2020-06-16 | 2020-06-16 | 4 | RTW INVESTMENTS, LP By RTW Investments, LP | RNA | Common Stock | I | 3.045.000 | 3.045.000 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series C Preferred Stock | I | -108.504 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series B Preferred Stock | I | -35.374 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Series A Preferred Stock | I | -254.907 | 0 | ||||||
| 2020-06-16 | 2020-06-16 | 4 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 189.042 | 805.301 | ||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD | RNA | Common Stock | D | 1.090.303 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 1 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 2 | RNA | Common Stock | I | 936.238 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 3 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By trust FBO Child 4 | RNA | Common Stock | I | 912.536 | ||||||||
| 2020-06-11 | 3 | WILSON TROY EDWARD By family trust | RNA | Common Stock | I | 1.516.944 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 | ||||||||
| 2020-06-11 | 3 | LEVIN ARTHUR A By family trust | RNA | Common Stock | I | 588.286 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
